Impact of nutrition status and body mass index on mortality in hospitalized general medical patients: A prospective observational study.

BACKGROUND: Malnutrition and low body mass index (BMI) are risk factors for mortality in hospitalized patients. Data substantiating this are unavailable for hospitalized general medical patients in our setting. We studied the prevalence of malnutrition among patients admitted to general medical wards in a tertiary care hospital and its role as a risk factor for 1-month mortality. We also investigated the association of BMI with mortality. METHODS: In this prospective observational study, nutrition assessment using Subjective Global Assessment (SGA) and anthropometric measurements was performed in 395 hospitalized general medical patients. Charlson Comorbidity Index (CCI) and Modified Early Warning System (MEWS) score were calculated. Clinical course and vital status at 1 month after discharge was noted. Factors associated with mortality were identified using logistic regression. RESULTS: The mean age of the study population was 46.2 + 16.1 years; 247 (62.5%) were males. Of 395 patients, 129 (32.7%) belonged to SGA A, 155 (39.2%) to SGA B, and 111 (28.1%) to SGA C. Mean (±SD) BMI was 23.38 (±5.33); 141 (35.6%) were obese. Mortality was observed in 61 (15.4%) patients. Patients in the lowest BMI quartile had the lowest mortality. The adjusted regression analysis showed that higher age and MEWS scores were independently associated with mortality. Severe malnourishment (SGA C) was another important predictor. Further, the odds of death increased consistently across the consecutive BMI quartiles. CONCLUSION: Higher age, higher MEWS scores, severe malnourishment, and higher BMI scores were independent risk factors for 1-month mortality in hospitalized general medical patients.

Acute kidney injury in patients hospitalized with febrile urinary tract infections: A prospective observational study.

BACKGROUND: Febrile urinary tract infection (fUTI) can be associated with acute kidney injury (AKI). We aimed to study the risk factors for AKI, its pathophysiological categories, and the role of urinary neutrophil gelatinase-associated lipocalin (uNGAL) in differentiating these categories in patients hospitalized with fUTI. MATERIALS AND METHODS: We prospectively studied patients with fUTI admitted to the Department of Medicine of a tertiary care hospital in southern India from January 2017 to December 2018. Clinical evaluation, renal imaging, and estimation of fractional excretion of sodium (FeNa) and uNGAL were done at baseline. AKI was defined as ≥ 0.3 mg/dL rise in serum creatinine (SCr) within 48 hours during hospital stay (KDIGO criterion) or discharge SCr value 0.5 mg/dL or less compared to peak SCr after admission. RESULTS: We studied 100 patients. Their mean age was 52 (± 14) years; 45 were men. In all, 52 had AKI: pre-renal in 11 (21%), intrinsic renal in 24 (47%), post-renal in 16 (31%), and missing data 1 patient. uNGAL levels were significantly higher in the AKI group compared to the no-AKI group (median [IQR] 91.1 [13.2 - 188] vs. 264.9 [115.2 - 355.2] ng/mL; p < 0.001). On multivariable analysis, male sex (adjusted odds ratio, aOR [95% CI] 2.8 [1.09 - 7.14]), hypertension (4.12 [1.24 - 13.7]) and hydroureteronephrosis (7.82 [1.55 - 39.4]) were independently associated with AKI. There was an increasing trend of uNGAL across the three categories of AKI (pre-renal 106.1 [14.6 - 261.7] ng/mL, intrinsic renal 210.8 [8.5 - 353.8] ng/mL, and post-renal 335.5 [269.2 - 692.8] ng/mL; p = 0.001). Patients with pre-renal AKI had significantly lower levels of uNGAL compared to the other two categories combined (106.1 [14.6 - 261.7] vs. 284.6 [179 - 434.4] ng/mL; p = 0.016). CONCLUSION: Hospitalized fUTI patients should be evaluated for AKI, and obstructive uropathy should be ruled out in those with AKI. uNGAL levels may help in differentiating the pre-renal type of AKI from the other two categories.

Frequency and clinical significance of prostatic involvement in men with febrile urinary tract infection: a prospective observational study.

Background: Frequent asymptomatic involvement of the prostate has been demonstrated in men with febrile urinary tract infection (fUTI). In view of this, men with fUTI are often given a longer duration of antibiotic treatment; however, evidence to support this is limited. Methods: We prospectively studied adult men with fUTI admitted under the Department of Medicine in a tertiary care hospital in southern India.  fUTI was defined as fever of ≥38°C with at least one symptom/sign of UTI and pyuria, requiring hospitalization. We estimated serum total prostate-specific antigen (PSA) levels at enrollment, one month and three months after treatment completion. We assessed prostatic volume by transrectal ultrasonography (TRUS) and estimated the serum high sensitivity C-reactive protein (hs-CRP) levels at baseline and after three months. Results: We enrolled 64 men (median [IQR] age 53 [45-60] years); 50 patients completed follow-up. At baseline, the median (IQR) serum PSA level was 2.15 (1.18-3.02) ng/mL and median (IQR) serum hs-CRP level was 2.43 (2.28-2.58) mg/L. At three months, serum PSA levels decreased by ≥25% in 47 (94%) of 50 patients. The median (IQR) of prostatic volume was 25.4 (18.9-34) mL at baseline, and ≥10% decrease in prostatic volume was observed in 24 (48%) of 50 patients at three months. The change in the serum PSA levels did not correlate with clinical findings like prostatic tenderness or with prostatic volume changes. Further, serum PSA levels did not correlate with hs-CRP levels. On follow-up, seven patients had lower urinary tract symptoms; only one of them had recurrent fUTI.   Conclusions: Asymptomatic prostatic involvement, although common in men with fUTI, does not seem to influence the treatment outcomes.